Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Biochimie ; 182: 206-216, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33485932

ABSTRACT

The elapid genus, Micruroides, is considered the sister clade of all New World coral snakes (Genus Micrurus), is monotypic, and is represented by Sonoran Coral Snakes, Micruroides euryxanthus. Coral snakes of the genus Micrurus have been reported to have venoms that are predominantly composed of phospholipases A2 (PLA2) or three finger toxins (3FTx), but the venoms of the genus Micruroides are almost completely unstudied. Here, we present the first description of the venom of M. euryxanthus including identification of some proteins as well as transcriptomic, and biological activity assays. The most abundant components within M. euryxanthus venom are 3FTxs (62.3%) and there was relatively low proportion of PLA2s (14.2%). The venom phenotype supports the hypothesis that the common ancestor of Micrurus and Micruroides had a 3FTx-dominated venom. Within the venom, there were two nearly identical α-neurotoxins (α-Ntx), one of which was designated Eurytoxin, that account for approximately 60% of the venom's lethality to mice. Eurytoxin was cloned, expressed in a soluble and active form, and used to produce rabbit hyperimmune serum. This allowed the analysis of its immunochemical properties, showing them to be different from the recombinant αNTx D.H., present in the venoms of some species of Micrurus. Finally, we observed that the commercial antivenom produced in Mexico for coral snake envenomation is unable to neutralize the lethality from M. euryxanthus venom. This work allowed the classification of Micruroides venom into the 3FTx-predominant group and identified the main components responsible for toxicity to mice.


Subject(s)
Coral Snakes , Elapid Venoms , Phospholipases A2 , Reptilian Proteins , Animals , Coral Snakes/genetics , Coral Snakes/metabolism , Elapid Venoms/biosynthesis , Elapid Venoms/genetics , Phospholipases A2/biosynthesis , Phospholipases A2/genetics , Reptilian Proteins/biosynthesis , Reptilian Proteins/genetics , Species Specificity
2.
J. venom. anim. toxins incl. trop. dis ; 27: e20200068, 2021. tab, graf
Article in English | LILACS, VETINDEX | ID: biblio-1154772

ABSTRACT

Maintenance of snakes at Butantan Institute started in the last century, intending to produce a different antivenom serum to reduce death caused by snakebites. Through a successful campaign coordinated by Vital Brazil, farmers sent venomous snakes to Butantan Institute by the railway lines with no cost. From 1908 to 1962, the snakes were kept in an outdoor serpentarium, where venom extraction was performed every 15 days. During this period, the snake average survival was 15 days. In 1963, the snakes were transferred to an adapted building, currently called Laboratory of Herpetology (LH), to be maintained in an intensive system. Although the periodicity of venom extraction remained the same, animal average survival increased to two months. With the severe serum crisis in 1983, the Ministry of Health financed remodeling for the three public antivenom producers, and with this support, the LH could be improved. Air conditioning and exhausting systems were installed in the rooms, besides the settlement of critical hygienic-sanitary managements to increase the welfare of snakes. In the early 1990s, snake survival was ten months. Over the years to the present day, several improvements have been made in the intensive serpentarium, as the establishment of two quarantines, feeding with thawed rodents, an interval of two months between venom extraction routines, and monitoring of snake health through laboratory tests. With these new protocols, average snake survival increased significantly, being eight years for the genus Bothrops, ten years for genus Crotalus and Lachesis, and four years for the genus Micrurus. Aiming the production of venoms of good quality, respect for good management practices is essential for the maintenance of snakes in captivity. New techniques and efficient management must always be sought to improve animal welfare, the quality of the venom produced, and the safety of those working directly with the venomous snakes.(AU)


Subject(s)
Animals , Snake Bites , Viperidae , Elapid Venoms/biosynthesis , Animal Welfare , Costs and Cost Analysis
3.
Int J Biol Macromol ; 162: 1283-1292, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-32562730

ABSTRACT

Breast cancer (BC) is among the leading causes of mortality from cancer in women. Many of the available anticancer drugs have various side effects. Therefore, researchers are seeking novel anticancer agents particularly from natural compounds and in this regard, snake venom is still one of the main sources of drug discovery. Previous studies showed potential anticancer effects of Cytotoxin II (CTII) from Naja naja oxiana against the different types of cancers. In this study, a pET-SUMO-CTII vector was transformed into SHuffle® T7 Express, an Escherichia coli strain, for recombinant protein expression (rCTII) and the cytotoxic effects of this protein was assessed in MCF-7 cells. The flow cytometry assay was applied to measure the apoptosis and cell cycle. Also, mRNA levels of the Bax, Bcl2, P53, caspase-3, caspase-8, caspase-9, caspase-10, matrix metalloproteinases (MMP)-3, and MMP-9 were analyzed by quantitative real-time PCR to determine the underlying cellular pathways affected by rCTII. The results of this study showed that treatment with 4 µg mL-1 of rCTII enhanced apoptosis through the intrinsic and extrinsic pathways. Also, the increase of the cells' proportion in the sub-G1 phase as well as a reduction in S phase was observed. In addition, the expression of MMP-3 and MMP-9 was decreased in the treated group in comparison to the control group that may contribute to the reduced migratory ability of tumor cells. These experimental results indicate that rCTII has anti-proliferative potential, and so this protein could be a potential drug for BC therapy in combination with other drugs.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Breast Neoplasms/drug therapy , Cytotoxins/pharmacology , Elapid Venoms , Naja naja/genetics , Animals , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Elapid Venoms/biosynthesis , Elapid Venoms/genetics , Elapid Venoms/pharmacology , Female , Humans , MCF-7 Cells , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology
4.
J Proteomics ; 159: 19-31, 2017 04 21.
Article in English | MEDLINE | ID: mdl-28263888

ABSTRACT

We conducted an omics-analysis of the venom of Naja kaouthia from China. Proteomics analysis revealed six protein families [three-finger toxins (3-FTx), phospholipase A2 (PLA2), nerve growth factor, snake venom metalloproteinase (SVMP), cysteine-rich secretory protein and ohanin], and venom-gland transcriptomics analysis revealed 28 protein families from 79 unigenes. 3-FTx (56.5% in proteome/82.0% in transcriptome) and PLA2 (26.9%/13.6%) were identified as the most abundant families in venom proteome and venom-gland transcriptome. Furthermore, N. kaouthia venom expressed strong lethality (i.p. LD50: 0.79µg/g) and myotoxicity (CK: 5939U/l) in mice, and showed notable activity in PLA2 but weak activity in SVMP, l-amino acid oxidase or 5' nucleotidase. Antivenomic assessment revealed that several venom components (nearly 17.5% of total venom) from N. kaouthia could not be thoroughly immunocaptured by commercial Naja atra antivenom. ELISA analysis revealed that there was no difference in the cross-reaction between N. kaouthia and N. atra venoms against the N. atra antivenom. The use of commercial N. atra antivenom in treatment of snakebites caused by N. kaouthia is reasonable, but design of novel antivenom with the attention on enhancing the immune response of non-immunocaptured components should be encouraged. BIOLOGICAL SIGNIFICANCE: The venomics, antivenomics and venom-gland transcriptome of the monocoled cobra (Naja kaouthia) from China have been elucidated. Quantitative and qualitative differences are evident when venom proteomic and venom-gland transcriptomic profiles are compared. Two protein families (3-FTx and PLA2) are found to be the predominated components in N. kaouthia venom, and considered as the major players in functional role of venom. Other protein families with relatively low abundance appear to be minor in the functional significance. Antivenomics and ELISA evaluation reveal that the N. kaouthia venom can be effectively immunorecognized by commercial N. atra antivenom, but still a small number of venom components could not be thoroughly immunocaptured. The findings indicate that exploring the precise composition of snake venom should be executed by an integrated omics-approach, and elucidating the venom composition is helpful in understanding composition-function relationships and will facilitate the clinical application of antivenoms.


Subject(s)
Elapid Venoms/biosynthesis , Exocrine Glands/metabolism , Gene Expression Profiling , Naja naja/metabolism , Transcriptome/physiology , Animals , Antivenins , Elapid Venoms/genetics , Naja naja/genetics
5.
Toxicon ; 88: 11-20, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24951874

ABSTRACT

Notexin (Ntx) is a group I phospholipase A2 (PLA2) protein, main component of the Australian snake Notechis scutatus scutatus venom. It is both a presynaptic neurotoxin and a myotoxin. In this work, for the first time, a method for the production and folding of recombinant Ntx was developed. Ntx was produced with wild type sequence (rNtx), with an extra peptide (T7-Ntx) or a methionine (M-Ntx) before Asn-1, and with Asn-1 substituted by alanine (Ntx-A1) or by serine (Ntx-S1). The proteins were analyzed for their catalytic and toxic activities. rNtx activity resulted to be comparable to that of the venom extracted protein. The Ntx N-terminus was found to have a major influence on both the catalytic and toxic activities of the protein. The first amino acid of snake venom PLA2s is highly conserved: it is an asparagine in about all group I PLA2s, while in most (>70%) of group II PLA2s it is a serine or an asparagine. Interestingly, Ntx-S1 resulted to be, for both enzymatic and toxic activities, the mutant most similar to the wild type protein. The role of the catalytic activity of Ntx in its toxicity was investigated by replacing the aspartic acid 49, involved in the coordination of the cofactor calcium ion, by a lysine. The obtained mutant (Ntx-K49) is deprived of catalytic activity but possesses a residual toxicity.


Subject(s)
Elapid Venoms/biosynthesis , Escherichia coli/genetics , Mutation , Protein Folding , Recombinant Proteins/biosynthesis , Amino Acid Sequence , Animals , Catalytic Domain , Elapid Venoms/chemistry , Elapid Venoms/genetics , Elapid Venoms/isolation & purification , Elapid Venoms/toxicity , Mice , Molecular Sequence Data , Phospholipases A2/metabolism , Rats , Rats, Wistar , Recombinant Proteins/isolation & purification
6.
Toxicon ; 60(3): 249-53, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22538193

ABSTRACT

American Elapid snakes (Coral Snakes) comprise the genera Leptomicrurus, Micruroides and Micrurus, which form a vast taxonomic assembly of 330 species distributed from the South of United States to the southern region of South America. In order to obtain venom for animal immunizations aimed at antivenom production, Coral Snakes must be kept in captivity and submitted periodically to venom extraction procedures. Thus, to maintain a snake colony in good health for this purpose, a complete alternative diet utilizing an easily obtained prey animal is desirable. The development of a diet based on fish is compared to the wild diet based on colubrid snakes, and assessed in terms of gain in body weight rate (g/week), longevity (weeks), venom yield (mg/individual), venom median lethal dose (LD50) and venom chromatographic profiles. The animals fed with the fish-based diet gained more weight, lived longer, and produced similar amount of venom whose biological and biochemical characteristics were similar to those of venom collected from specimens fed with the wild diet. This fish-based diet appears to be suitable (and preferable to the wild diet) to supply the nutritional requirements of a Micrurus nigrocinctus snake collection for the production of antivenom.


Subject(s)
Animal Husbandry , Antivenins/biosynthesis , Cichlids , Diet/veterinary , Elapid Venoms/biosynthesis , Elapidae/growth & development , Animals , Antivenins/chemistry , Antivenins/isolation & purification , Antivenins/toxicity , Biological Assay/veterinary , Costa Rica , Drug Industry , Elapid Venoms/chemistry , Elapid Venoms/isolation & purification , Elapid Venoms/toxicity , Elapidae/metabolism , Immunologic Factors , Lethal Dose 50 , Mice , Muscle, Skeletal/chemistry , Reptilian Proteins/analysis , Weight Gain
7.
J Immunol ; 173(9): 5540-5, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15494503

ABSTRACT

From the implications of the complement system in a large number of diseases, an urgent need for therapeutics effecting reduced complement activity in vivo has emerged. In this study we report the design of a novel class of enzymes of human origin that obliterate functional complement by a noninhibitory, catalytic mechanism. Combining the framework of human C3 and the enzymatic mechanism of cobra venom factor, a nontoxic snake venom protein, we established molecules capable of forming stable C3 convertase complexes. Although the half-life of naturally occurring C3 convertase complexes ranges between 1 and 2 min, these complexes exhibit a half-life of up to several hours. Because the overall identity to human C3 could be extended to >90%, the novel C3 derivatives can be assumed to exhibit low immunogenicity and, therefore, represent promising candidates for therapeutic reduction of complement activity in vivo.


Subject(s)
Complement C3/antagonists & inhibitors , Complement C3/physiology , Complement Inactivator Proteins/physiology , Recombinant Proteins/pharmacology , Animals , CHO Cells , Catalysis , Complement Activation/immunology , Complement C3/isolation & purification , Complement C3/metabolism , Complement C3-C5 Convertases/chemical synthesis , Complement Inactivator Proteins/isolation & purification , Complement Pathway, Alternative , Cricetinae , Elapid Venoms/biosynthesis , Elapid Venoms/genetics , Erythrocytes/immunology , Humans , Immune Sera/blood , Protein Structure, Tertiary/genetics , Sheep , Transfection
8.
J Thromb Haemost ; 1(3): 545-50, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12871464

ABSTRACT

Trocarin is a 46515-Da group D prothrombin-activating glycoprotein from the venom of the Australian elapid, Tropidechis carinatus. Amino acid sequencing and functional characterization of trocarin demonstrated that it is a structural and functional homolog of mammalian blood coagulation factor (F)Xa. In this study we show that, in contrast to mammalian Xa, which is not glycosylated, trocarin contains an O-linked carbohydrate moiety in its light chain and an N-linked carbohydrate oligosaccharide in its heavy chain. Mass spectrometry and sugar compositional analysis indicate that the O-linked carbohydrate moiety is a mixture of Xyl-GlcNAc-, GlcNAc-, Xyl-Glc- and Glc- structures linked to Ser 52. The N-linked carbohydrate on Asn 45 of the heavy chain is a sialylated, diantennary oligosaccharide that is located at the lip of the active site of the prothrombin activator.


Subject(s)
Disaccharides/analysis , Prothrombin/analysis , Acetylglucosamine/metabolism , Carbohydrate Sequence , Elapid Venoms/biosynthesis , Elapid Venoms/chemistry , Factor Xa , Glycosylation , Golgi Apparatus , Humans , Molecular Sequence Data , Protein Processing, Post-Translational , Prothrombin/biosynthesis , Prothrombin/chemistry
9.
J Comp Neurol ; 455(4): 417-34, 2003 Jan 20.
Article in English | MEDLINE | ID: mdl-12508317

ABSTRACT

The Drosophila N-CAM homolog Fasciclin II (FasII) is expressed during the embryonic period in a subset of central neurons that pioneer the neuropile of the larval brain. Toward the end of embryogenesis, FasII expression in axon tracts diminishes but resumes from the late first larval instar in an increasingly complex pattern of axon tracts that join the tracts laid down in the embryo. We present evidence that FasII is expressed in a major fraction of the long axon tracts that interconnect different domains of the larval brain. For many tracts, FasII expression remains stable throughout larval development and pupal development. Therefore, the FasII pattern of axon tracts, along with the mushroom body and optic lobe, both of which are also FasII-positive, represents a useful set of landmarks that define different regions in the Drosophila brain throughout development. In this study, serial confocal brain sections were used to generate digital three-dimensional models of larval axon tracts at different stages. These models form part of our effort to generate an anatomic framework of Drosophila larval brain structure required for accurate localization of gene expression and gene function in experimental studies of neural development.


Subject(s)
Brain/anatomy & histology , Brain/growth & development , Drosophila melanogaster/anatomy & histology , Models, Anatomic , Neuropil/cytology , Animals , Antigens, Differentiation/biosynthesis , Axons/metabolism , Axons/ultrastructure , Brain/cytology , Elapid Venoms/biosynthesis , Imaging, Three-Dimensional , Larva/anatomy & histology , Larva/cytology , Larva/growth & development , Morphogenesis , Neuropil/metabolism
10.
J Nat Toxins ; 11(4): 393-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12503884

ABSTRACT

Sea snake venoms contain less protein than those of land snakes (Toom et al., 1969). Sea snake venoms lack arginine ester hydrolyzing activity, whereas those of Crotalidae and Viperidae have such activity (Tu et al., 1966). Sea snakes live in salty water, and their venoms may be different from those of land snakes. Because of the difficulty in obtaining sea snake venoms, information about sea snake venoms is quite incomplete. NGF is commonly present in the venoms of land snakes such as Elapidae, Viperidae, and Crotalidae (Cohen and Levi-Montalcini, 1956; Lipps, 2002). It is therefore of interest to investigate the presence or absence of NGF in sea snake venoms. In order to investigate the presence or absence of NGF, five sea snake venoms were selected. Lapemis hardwickii (Hardwick's sea snake) and Acalyptophis peronii venom were obtained from the Gulf of Thailand. Hydrophis cyanocinctus (common sea snake) and Enhydrina schistosa (beaked sea snake) venom were obtained from the Strait of Malacca. Laticauda semifasciata (broad band blue sea snake) venom was also examined and the venom was obtained from Gato Island in the Philippines.


Subject(s)
Elapid Venoms/metabolism , Elapidae , Nerve Growth Factor/biosynthesis , Animals , Chick Embryo , Elapid Venoms/biosynthesis , Ganglia, Spinal/drug effects , Nerve Growth Factor/pharmacology , Neurotoxins/biosynthesis
11.
Toxicon ; 40(11): 1581-92, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12419509

ABSTRACT

The rates at which venomous animals produce venoms are of obvious biological and medical importance, but factors influencing those rates remain poorly understood. We gathered data on venom yield (wet mass of venom) and percentage solids (dry mass of the venom divided by wet mass) for 53 eastern brownsnakes (Pseudonaja textilis) and 36 mainland tigersnakes (Notechis scutatus) over a 4-year period at Venom Supplies Pty. Ltd, a commercial venom production facility in South Australia. Tigersnakes yielded about threefold more venom (by wet mass) than brownsnakes, but with slightly lower percentage solids. Both species showed significant geographic variation in percentage solids. Venom yields varied as a function of the snake's sex and geographic origin, but these effects were secondary consequences of geographic and sex-based differences in body size. Relative head size affected venom yield in brownsnakes but not tigersnakes. Overall, the amount of venom that a snake produced during milking was affected by its species, its geographic origin, its body size and relative head size, and by the time of year that it was milked, as well as by interactions among these factors. Body size was the most important effect on venom yield, with yields increasing more rapidly with size in brownsnakes than in tigersnakes. Research at the intersection of snake ecology and venom characteristics has great potential, but will require a genuinely interdisciplinary approach.


Subject(s)
Elapid Venoms/biosynthesis , Elapidae/physiology , Animals , Australia , Elapidae/anatomy & histology , Female , Geography , Male , Seasons
12.
Sheng Wu Gong Cheng Xue Bao ; 16(3): 312-5, 2000 May.
Article in Chinese | MEDLINE | ID: mdl-11059270

ABSTRACT

The cDNA encoding the precursor of cobrotoxin was cloned from the venom gland of the Chinese continental cobra (Naja naja atra) by RT-PCR. Its deduced amino acid sequence analysis showed that the mature protein was identical to that identified from the Taiwan cobra (Naja naja atra) by protein sequencing technique. The cDNA encoding the mature protein was then subcloned into the expression vector pMAL-P2. The gene of CM11, which was formed by ligation of the fragments of the synthetic oligonucleotides, was also cloned into the expression vector pMAL-P2. After induction of IPTG, both of the neurotoxins were overexpressed as soluble fusion proteins which were confirmed by SDS-PAGE and western blotting. The expressed fusion proteins was purified by sepharose 6B-amylose affinity chromatography and DEAE-sepharose FF chromatography. Both of the recombinant proteins achieved after digestion by factor Xa showed the in vivo toxicity.


Subject(s)
Elapid Venoms/biosynthesis , Neurotoxins/biosynthesis , Recombinant Fusion Proteins/biosynthesis , Animals , Base Sequence , Elapid Venoms/genetics , Female , Male , Mice , Molecular Sequence Data , Neurotoxins/genetics , Reverse Transcriptase Polymerase Chain Reaction
13.
Biochemistry ; 38(49): 16290-7, 1999 Dec 07.
Article in English | MEDLINE | ID: mdl-10587453

ABSTRACT

Acidic phospholipase A2 (PLA2) from the venom of Chinese cobra (Naja naja atra) has high activity on zwitterionic membranes and contains six aromatic residues, including Tyr-3, Trp-18, Trp-19, Trp-61, Phe-64, and Tyr-110, on its putative interfacial binding surface. To assess the roles of these aromatic residues in the interfacial catalysis of N. n. atra PLA2, we mutated them to Ala and measured the effects on its interfacial catalysis. Enzymatic activities of the mutants toward various vesicle substrates and human neutrophils indicate that all but Trp-18 make significant contributions to interfacial catalysis. Among these aromatic residues, Trp-19, Trp-61, and Phe-64 play the most important roles. Binding affinities of the mutants for phospholipid-coated beads and their monolayer penetration indicate that Trp-19, Trp-61, and Phe-64 are critically involved in interfacial binding of N. n. atra PLA2 and penetrate into the membrane during the interfacial catalysis of N. n. atra PLA2. Further thermodynamic analysis suggests that the side chain of Phe-64 is fully inserted into the hydrophobic core of membrane whereas those of Trp-19 and Trp-61 are located in the membrane-water interface. Together, these results show that all three types of aromatic residues can play important roles in interfacial binding of PLA2 depending on their location and side-chain orientation. They also indicate that these aromatic side chains interact with membranes in distinct modes because of their different intrinsic preference for different parts of membranes.


Subject(s)
Amino Acids, Cyclic/chemistry , Elapid Venoms/enzymology , Phospholipases A/chemistry , Amino Acid Sequence , Animals , Base Sequence , Binding Sites/genetics , Elapid Venoms/biosynthesis , Elapid Venoms/genetics , Elapid Venoms/metabolism , Enzyme Activation , Humans , Kinetics , Liposomes/metabolism , Methoxyhydroxyphenylglycol/analogs & derivatives , Methoxyhydroxyphenylglycol/metabolism , Molecular Sequence Data , Mutagenesis, Site-Directed , Phenylalanine/chemistry , Phospholipases A2 , Phospholipid Ethers/metabolism , Phospholipids/chemistry , Phospholipids/metabolism , Polymers/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tryptophan/chemistry , Tyrosine/chemistry
14.
Toxicon ; 33(4): 459-74, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7570631

ABSTRACT

Mamba venoms contain pharmacologically active proteins that interfere with neuromuscular transmission by binding to and altering the normal functioning of neuronal proteins involved, directly or indirectly, with regulating nerve transmission. Of the mamba toxins studied to date, many act on voltage-sensitive K+ channels, nicotinic or muscarinic acetylcholine receptors, or acetylcholinesterase. In an attempt to clone, characterize, and express the genes encoding these toxins, as well as other genes specifying activities not completely elucidated as yet, a cDNA library was constructed from mRNA isolated from the glands of the black mamba. Clones from the library harboring sequences encoding 14 different mamba toxins were isolated and characterized by nucleotide sequence analysis. Genes coding for three proteins, dendrotoxins (DTX) K, I, and E, were expressed as maltose-binding (MBP) fusion proteins in the periplasmic space of Escherichia coli. The DTXK-MBP fusion protein was affinity purified, cleaved from its chaperon, and the recombinant DTXK purified from MBP. Recombinant DTXK was shown to be identical to native DTXK in its N-terminal sequence, chromatographic behavior, convulsion-inducing activity, and binding to voltage-activated K+ channels in bovine synaptic membranes. Computer modeling was employed to create three-dimensional structures of DTXK and DTX1 from the X-ray crystal structure of alpha-DTX utilizing both structural and sequence homologies. Comparisons were made between the three toxins, providing a framework for site-directed mutagenesis.


Subject(s)
Elapid Venoms/biosynthesis , Neurotoxins/biosynthesis , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Computer Simulation , DNA, Complementary/biosynthesis , Elapid Venoms/genetics , Elapid Venoms/isolation & purification , Electrophysiology , Escherichia coli/metabolism , Gene Expression/drug effects , Molecular Sequence Data , Neurotoxins/genetics , Neurotoxins/isolation & purification , Polymerase Chain Reaction , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Recombinant Fusion Proteins/biosynthesis , Recombinant Proteins/biosynthesis
16.
Eur J Biochem ; 212(2): 441-6, 1993 Mar 01.
Article in English | MEDLINE | ID: mdl-8444182

ABSTRACT

We have constructed an expression vector to produce, in Escherichia coli, a fusion protein containing successively two IgG binding domains from staphyloccocal protein A, a nine-amino-acid linker peptide terminating in a methionine residue and the phospholipase A2 notechis 11'2L, an isoform of notexin of Notechis scutatus scutatus venom. Notechis 11'2L is a mutant of the naturally occurring notechis 11'2 [Bouchier, C., Boyot, P., Tesson, F., Trémeau, O., Bouet, F., Hodgson, D., Boulain, J. C. & Ménez, A. (1991) Eur. J. Biochem. 202, 493-500] in which Met8 has been replaced by Leu. The fusion protein was recovered in the periplasmic extract with a yield of 0.25 mg/l culture. It was hydrolyzed with cyanogen bromide, yielding a protein having the molecular mass, amino acid composition and N-terminal sequence of notechis 11'2L. Notechis 11'2L and the wild notechis 11'2 displayed identical circular dichroic spectra and shared similar enzymatic, myotoxic and antigenic properties, suggesting that the recombinant notechis 11'2L was directly generated in a correctly folded form.


Subject(s)
Elapid Venoms/biosynthesis , Escherichia coli/metabolism , Phospholipases A/biosynthesis , Recombinant Fusion Proteins/biosynthesis , Base Sequence , Elapid Venoms/chemistry , Elapid Venoms/genetics , Elapid Venoms/isolation & purification , Molecular Sequence Data , Mutation , Phospholipases A/chemistry , Phospholipases A/genetics , Phospholipases A/isolation & purification , Phospholipases A2 , Protein Folding
SELECTION OF CITATIONS
SEARCH DETAIL
...